COVID-19 & Emerging Diseases

“When COVID-19 emerged, we realized that we had to pivot to quickly mobilize the resources needed in order to respond to the urgent calls for assistance that we were receiving.”

— Wafaa El-Sadr, ICAP Director

From the moment the first evidence of the coronavirus pandemic appeared in late 2019, ICAP at Columbia University recognized the potentially devastating impact of COVID-19 in many of the countries where it works, countries where health systems are particularly fragile. Building on nearly two decades of experience in responding to the world’s most significant public health challenges and harnessing its longstanding partnerships with ministries of health across the globe, ICAP mounted a comprehensive response to COVID-19 in 24 countries in Africa, Asia, and the Americas in partnership with stakeholders in each of the countries.

With tens of millions of dollars in funding raised through relentless efforts and a mandate to act quickly in the face of a dangerous and rapidly spreading disease, ICAP directed its teams and these resources to create firewalls of detection, prevention, and response to stand between the spreading virus and the communities in its path.

ICAP’s ongoing response to the continuing pandemic has spanned the gamut of public health activities, including:

  • Training of health workers
  • Standing up emergency operation centers
  • Establishing fever clinics and health brigades
  • Procuring personal protective and medical equipment
  • Identifying new prevention and treatment methods
  • Optimizing infection prevention and control
  • Supporting surveillance and conducting surveys

COVID-19 News

SILVER Study Reveals Continued Mental Health Distress Experienced by Older New Yorkers from the COVID-19 Pandemic

(Gulf Business) Pandemic travel has reached a tipping point

(Bloomberg) Will Vaccines Protect Me From Long Covid?

(YAHOO NEWS) How does reinfection impact long COVID? Here’s what we know so far

(Bloomberg) I Just Got Boosted. Why Did I Catch Covid?

(NY1) What to know about the ‘triple threat’ of RSV, COVID and flu

(Bloomberg) Is COVID getting less deadly?

(Bloomberg) Pandemic Travel Has Reached a Turning Point

(City & State) Editor’s note: Could mask-only subway cars make everyone happy?

(ABC News) Which states have the lowest COVID-19 vaccination rates?

(Bloomberg) How Safe Are the New Covid Boosters?

(Yahoo News) New Omicron-targeting COVID-19 boosters are approved. Here’s what you need to know.

COVID-19 Resources

SILVER Study Among Older New Yorkers: Round 2

Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19

ICAP Grand Rounds (Archived Recording) – COVID-19 and Older New Yorkers: Findings from the SILVER II Survey

COVID-19 Clinical Management Training Package

Fighting COVID-19 pandemic fatigue and complacency in Zimbabwe

Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain

Hesitancy, ignorance or uncertainty? The need for effective communication strategies as Zimbabwe’s uptake of COVID-19 vaccine booster doses remains poor

Associations between living arrangement and sexual and gender minority stressors among university students since the start of the COVID-19 pandemic

COVID-19 vaccine uptake and factors associated with being unvaccinated among lesbian, gay, bisexual, transgender, queer, and other sexual identities (LGBTQ+) New Yorkers

Association between vaccination coverage disparity and the dynamics of the COVID-19 Delta and Omicron waves in the US

Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis

The case to scale up edutainment as an effective public health communication intervention to combat the COVID-19 pandemic in Zimbabwe